A study of cannabidiol as treatment for severe symptoms of autism in Pediatric patients
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2018
At a glance
- Drugs Cannabidiol (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 12 Oct 2018 According to an INSYS Therapeutics, Inc media release, the company anticipates the filing of IND (investigational new drug) application for the study in the fourth quarter of 2018.
- 03 May 2018 New trial record
- 26 Apr 2018 According to an INSYS Therapeutics media release, the company announced collaboration with the University of California (UC) San Diego School of Medicines Center for Medicinal Cannabis Research (CMCR) to conduct this study in 2019.